Tuesday , October 17 2017
Home / KEEP BUT DO NOT DISPLAY / Alerts / Roche stops diabetes drug development following safety concerns.

Roche stops diabetes drug development following safety concerns.

Roche stops diabetes drug development following safety concerns.

Roche Holding announced it will cease the development of its diabetes drug aleglitazar after a late-stage trial revealed the medication negatively affects the kidneys and the heart.